Alternate Title: DEA Intelligence Report: Counterfeit Controlled Prescription Drug Availability in Pennsylvania & Delaware
From the Document: "The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) is advising law enforcement and public health counterparts of the increased availability of counterfeit controlled prescription drugs (CPDs) - commonly sold as legitimate CPDs with most containing fentanyl/ fentanyl-related compounds (FRC) - in Pennsylvania and Delaware. First observed as early as 2015, when they were acquired primarily through Dark Web suppliers, counterfeit CPDs have been seized with increasing frequency and quantity since that time, while several local production operations have also been identified and subsequently dismantled. Most recently, the increase in wholesale production and trafficking of counterfeit CPDs by Mexican transnational criminal organizations (TCOs) further demonstrates this emerging threat."
DEA-PHL-DIR-035-20; Drug Enforcement Administration-Philadelphia-DEA Intelligence Report 035-20
Drug Enforcement Agency: https://www.dea.gov/